Pyxis Oncology

pyxisoncology.comBoston, United StatesMember of HARO Newswire since
Releases
1
First release
Most recent
Categories
Nasdaq:PYXS

Press releases from Pyxis Oncology

1 release

  1. Nasdaq:PYXS

    Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium

    Updated data from a more mature October 2026 data cutoff show rapid and deep responses, with a 39% confirmed ORR, median duration of response of 9.2 months and median PFS of 6.7 months Clinical activity consistent across HPV status and prior-treatment subgroups, with a…